320 Logue Avenue
14 articles with Cellecta, Inc.
Cellecta, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
Libraries of pooled lentiviral constructs that express two different sgRNA to all 19,000 human protein-coding genes improve overall gene activation or repression and generate more robust screening results
Five RNA-Seq assay panels target known gene sets associated with human disease, drug response, immune responses, related phenotypes
Cellecta, Inc. Introduces CloneTracker XP™ Expressed Lentiviral Barcode Libraries and CloneTracker XP™ Barcoded CRISPR Libraries
Label individual cells with uniquely identifiable, expressed barcodes to understand how different experimental conditions affect distinct groups of cells from a common progenitor.
ERS Genomics and Cellecta Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Tools and Services
Financial details of the agreement were not disclosed.
Cellecta, Inc. Introduces CRISPRa And CRISPRi Genome-Wide sgRNA Libraries And Mouse Genome-Wide CRISPR Knockout Library To Expand Functional Genomic Screening Portfolio
Cellecta, Inc. Launches Driver-Map Human Genome-Wide Gene Expression Profiling Kit For 19,000 Human Genes
Cellecta, Inc. Release: Biotech Receives Phase II NIH SBIR Grant To Develop Advanced CRISPR/Cas9 Genome-Wide sgRNA Library Screening Platform
Cellecta, Inc. Launches Driver-Map Human Genome-Wide Expression Profiling Service For 19,000 Human Genes
Cellecta, Inc. Receives NIH SBIR Grant To Develop Validated Crispr Knockout Library Of Guide RNA (sgRNA) Sequences